Ruxolitinib is used to treat intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. Myelofibrosis is a life-threatening bone marrow problem which is manifested by the following symptoms: enlarged spleen (splenomegaly), severe itching, fever, night sweats, weight loss, bone pain, or unusual tiredness or weakness. This medicine is also used to treat polycythemia vera in patients who have had received hydroxyurea without success.
This medicine is available only with your doctor’s prescription.
This product is available in the following dosage forms:
When you order, if you purchase a higher quantity, you get a lower price. That's TIERED PRICING!
We promise to provide you with the personal care and attention you need.
When you view prescription products on this site, you’ll notice that prices sometimes vary depending on the source country. You can feel free to make the most cost effective choice because we only source products from countries with the highest standards and regulations (currently Canada, UK, Australia and New Zealand).
For many products we offer a lower per unit cost when you purchase larger quantities. If your quantity is larger than what is available on this website, please contact us directly.
Brand-name and generic products are theraputically equivalent